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The discovery of novel cancer genes is one of the main goals in cancer research. Bioinformatics methods can be used to accel-
erate cancer gene discovery, which may help in the understanding of cancer and the development of drug targets. In this paper, 
we describe a classifier to predict potential cancer genes that we have developed by integrating multiple biological evidence, 
including protein-protein interaction network properties, and sequence and functional features. We detected 55 features that 
were significantly different between cancer genes and non-cancer genes. Fourteen cancer-associated features were chosen to 
train the classifier. Four machine learning methods, logistic regression, support vector machines (SVMs), BayesNet and deci-
sion tree, were explored in the classifier models to distinguish cancer genes from non-cancer genes. The prediction power of 
the different models was evaluated by 5-fold cross-validation. The area under the receiver operating characteristic curve for lo-
gistic regression, SVM, Baysnet and J48 tree models was 0.834, 0.740, 0.800 and 0.782, respectively. Finally, the logistic re-
gression classifier with multiple biological features was applied to the genes in the Entrez database, and 1976 cancer gene can-
didates were identified. We found that the integrated prediction model performed much better than the models based on the in-
dividual biological evidence, and the network and functional features had stronger powers than the sequence features in pre-
dicting cancer genes. 
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Cancer is an extremely complex genetic disease [1]. The 
identification of important cancer genes can bring dramatic 
therapeutic advances and prolong the lives of cancer pa-
tients [2]. It has been suggested that while 5%10% of hu-
man genes might contribute to cancer; currently, experi-
mentally validated cancer genes cover only about 1% of the 
human genome [3]. This fact implies that there are still 
hundreds or even thousands of cancer genes still to be iden-
tified.  
Traditional experimental approaches, such as linkage 
analysis and association studies, are time consuming, labo-
rious and error-prone [4]. Alternatively, with the availability 
of genome-wide sequences, and genomics and proteomics 
data, bioinformatics methods have been applied to identify 
potential cancer genes, significantly reducing the number of 
candidate genes for further testing [5]. Bioinformatics 
methods based either on gene annotation and sequence fea-
tures or on network analysis have provided powerful tools 
to accelerate cancer gene discovery [6–10]. For example, 
Furney et al. [6] identified some common structural, func-
tional and evolutionary properties of cancer genes and then 
used these properties to predict novel cancer genes. Ostlund 
et al. [7] proposed a network searching method, MaxLink, 
to find candidate cancer gene based on their connectivity to 
known cancer genes, and Li et al. [8] integrated network 
and functional properties to identify cancer genes. 
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With the accumulation of omics data, it becomes possible 
to collect, arrange, and integrate diverse biological evidence 
to build classifiers that can predict novel cancer genes more 
and more reliably. In this paper, we examined a large num-
ber of features from protein sequences, functional annota-
tions and interaction networks and analyzed systematically 
their roles in the identification of cancer genes. Using four 
machine learning algorithms, we established a valid classi-
fier that could distinguish cancer genes from other genes, 
and we evaluated its performance by cross-validation. Fi-
nally, the classifier was used to identify potential cancer 
genes in a gene database. 
1  Materials and methods 
1.1  Human interaction datasets 
Human protein-protein interaction (PPI) datasets were 
downloaded from the Online Predicted Human Interaction 
Database (OPID) [11]. We selected the literature-curated 
interactions from the BIND [12], HPRD [13] and MINT [14] 
databases. The selected interactions were all obtained ex-
perimentally and interactions based only on prediction re-
sults were excluded. This interaction dataset was integrated 
with a previous reported human signaling network that con-
tained 1643 nodes and 5089 signaling regulatory relations 
[15]. The total number of PPIs and number of unique pro-
teins in the final dataset was 47757 and 10016, respectively. 
1.2  Training dataset 
A dataset of cancer genes was collected from the Cancer 
Gene Census [2], the Online Mendelian Inheritance in Man 
(OMIM) [16], the Network for Cancer Genes (NCG) [17], 
the COSMIC database and a previously published list of 
candidate cancer genes [7], as shown in Table 1. The 
OMIM genes were identified by searching the annotations. 
By matching the disease annotations of the OMIM genes 
against cancer-specific terms, the cancer-related genes were 
identified and added to the set of known cancer genes. The 
COSMIC database contains the results of large-scale se-
quencing of tumor samples and provides mutation frequen-
cies for most of the cancer mutated genes to help identify 
genes that may be critical in the development of human 
cancers. Genes with 100% mutation frequencies were con- 
Table 1  Dataset of cancer genes used in this study 
Source Number 
Cancer Gene Census [2] 474 
Subset of OMIM [16] 329 
NCG [17] 1494 




sidered as cancer genes. After the removing redundancies, 
we obtained an integrated dataset that contained 2104 can-
cer genes. These genes made up the positive training dataset 
(Table S1 in Supporting Information). 
No verified non-cancer gene dataset was available. 
Therefore, we constructed a putative non-cancer gene da-
taset as follows: first, we excluded the Entrez genes [18] 
that were annotated as essential genes, because it has been 
reported that these genes have features which differ signifi-
cantly from both disease-genes and other non-essential 
genes [19]; next, we removed the disease genes listed in 
OMIM and called the remaining genes the ‘control-gene 
set’; and finally, we randomly selected genes that were 
equal in length to the cancer genes in the control-gene set as 
negative training dataset. The final training dataset consist-
ed of the genes in the sampled negative representative da-
taset (control group) and the fixed positive cancer dataset 
(cancer gene group).  
1.3  Feature selection 
Here, we used a simple and intuitive method, the F-score, to 
measure the power of discrimination of each feature. The 
F-score for feature i is defined as 
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where ix , 
( )
ix
 , ( )ix
  denote the mean values of feature i 
in all dataset, positive dataset and negative dataset. ( ),k ix
  is 
the value of feature i of gene k in the positive dataset, and 
( )
,k ix
  is the value of feature i of gene k in the negative da-
taset. High F-scores indicate a discriminative feature. 
1.4  Machine learning 
Four machine-learning algorithms were investigated: lo-
gistic regression, support vector machine (SVM) based on 
PolyKernel, BayesNet and J48 decision tree, all of which 
have been widely used for pattern classification and regres-
sion problems. The WEKA package [20] was used to build 
a classifier that could distinguish cancer genes from 
non-cancer genes, using selected features. A scaling scheme 
that restricted all entries to be between 0 and 1 was used for 
every vector, by calculating the (X-Min)/(Max-Min) for 
each feature, where X is the feature value, and Min and Max 
are the minimum and maximum values of X in the training 
dataset. 
We can evaluate the performance of the classifiers using 
5-fold cross-validation. During the test process, 20% of the 
genes in the positive and negative datasets were singled out 
in turn to become the test sample, and the remaining genes 
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were used as the training set to predict the class of the genes 
in the test sample. The performance was measured by the 
analysis of receiver operating characteristic (ROC) curves, 
which plot the true positive rate against the false positive 
rate at various thresholds [21]. The area under the ROC 
curve (AUC) provided the metric for the overall perfor-
mance of the classifier. The closer the AUC of a test was to 
1.0, the higher the overall efficacy of the test. 
2  Results and discussion 
We have developed an analysis pipeline to identify candi-
date cancer genes based on PPI networks, sequences and 
functional features. Our analysis of the differences between 
cancer genes and non-cancer genes revealed that cancer 
genes have functional, sequence and network characteristics 
that are distinctive from those of non-cancer genes. We used 
the distinctive features to generate a series of valid biologi-
cal features that could be included in the classifiers. We 
established the classifiers based on four machine learning 
methods, namely logistic regression, SVM, BayesNet and 
decision tree, and evaluated their performance by cross- 
validation. Finally, we applied the classifier based on the 
logistic regression method to the Entrez genes and identified 
a large number of potential cancer genes. 
2.1  Extraction of multiple biological features 
2.1.1  Network properties 
For each node i in the PPI network, we defined five 
measures to assess its topological properties: degree, 1N 
index, 2N index, shortest distance to cancer genes, and the 
clustering coefficient. Degree is defined as the number of 
proteins connected with node i and is the most widely used 
network property. 1N and 2N indexes are defined as the 
proportion of cancer genes in the neighbors of node i and in 
the neighbors’ neighbor of node i, as described previously 
[22]. The shortest distance to cancer genes measure was 
used to assess the communication efficiency of node i to 
cancer genes in the PPI network. It was assumed that a short 
distance would correspond to a quick transduction between 
node i and the cancer genes. 
A comparison of the five network measures between 
cancer genes and non-cancer genes is shown in Table 2. In 
the PPI network, the mean of the degree value for the cancer 
gene dataset was significantly higher than it was for the 
non-cancer genes, confirming a previous finding that the 
degree measure was higher for disease genes compared with 
non-disease genes [22]. The 1N and 2N indexes for the 
cancer genes were also significantly higher than those of 
non-cancer genes, suggesting that the neighbors of a cancer 
gene are more likely to be cancer genes than non-cancer 
genes, in agreement with a previous observation about dis-
ease genes [22]. We found that, in the control dataset, the 
shortest path to cancer genes was significantly higher than 
in the known cancer gene set, indicating that in the PPI 
network the cancer genes communicated quickly with each 
other. The clustering coefficient was similar for both the 
cancer gene and non-cancer gene datasets. 
2.1.2  Sequence properties 
The sequences of the proteins corresponding to the genes in 
the cancer and non-cancer datasets were analyzed to extract 
the main sequence properties. Hydrophobicity was calcu-
lated as the sum of hydrophobicity values for the amino acid 
residues using the Kyte and Doolittle index [23], divided by 
the number of residues in the corresponding protein se-
quence. We also computed the frequency of each amino 
acid in the protein sequence, as the number of each amino 
acid divided by protein length. The amino acids in each 
sequence were grouped as tiny, small, aliphatic, aromatic, 
non-polar, polar, charged or basic [24]. The Pepstats pro-
gram was used to calculate the protein sequence information 
statistics (http://emboss.bioinformatics.nl/cgi-bin/emboss/ 
pepstats) for 44 sequence properties, including hydrophobi-
city, molecular weight, number of residues, pI, amino acid 
frequencies and other properties.  
When the statistics of the sequence properties were 
compared, we found that the means of 19 sequence features 
were significantly different between the cancer proteins and 
non-cancer proteins (P-value<0.05, Table S2). The three 
properties that differed the most were the number of resi-
dues, molecular weight, and the A280 molar extinction co-
efficient. The cancer proteins tended to be longer than the 
non-cancer proteins, with mean number of residues of 868 
and 559, respectively. This finding is consistent with the 
description of cancer genes reported previously [5]. Corre-
spondingly, the mean molecular weight of the cancer pro-
teins (96517 Da) was significantly higher than for the 
non-cancer proteins (66255 Da) (P-value=9.11×1030). The 
frequencies of the amino acid in the protein sequences from 
the two datasets are shown in Figure 1. The differences in 
the frequencies of the Asn and Leu residues are the most 
significantly different between the two datasets (P-values= 
9.70×108 and 5.76×105, respectively). The cancer proteins 
tended to have more polar amino acids than the non-cancer 
proteins, which is similar to the findings of an earlier study 
Table 2  Topological features of the cancer gene and the control gene 
datasets in the PPI network 
Network measurea) Cancer Control P-value 
Degree 18.297 7.774 8.61×1027 
1N index 0.354 0.242 4.85×1026 
2N index 0.343 0.234 3.23×10113 
Shortest distance 1.368 1.804 1.64×1015 
Clustering coefficient 0.124 0.123 0.966 
a) All the values are given as means.
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Figure 1  Frequency of amino acids in protein sequences corresponding to the genes in the cancer and non-cancer datasets. 
of protein drug targets [24]. In general, cancer proteins have 
a significantly higher proportion of polar and small amino 
acids and a lower proportion of non-polar, aliphatic and 
basic amino acids in their sequences. 
2.1.3  Functional properties 
We used the Gene Ontology (GO) [25] which provides a 
controlled vocabulary to describe gene products, under three 
ontologies, biological process, molecular function, and cel-
lular component, to assign functional properties to the pro-
teins corresponding to the genes in the cancer and non- 
cancer dataset. In addition, the functional annotations from 
the Swiss-Prot database, under UP_SEQ_FEATURE and 
SP_PIR_KEYWORDS, were used to extract cancer-asso- 
ciated functional properties. 
Using the DAVID tool [26], we retrieved the GO and 
Swiss-Prot functional annotation terms for the known can-
cer genes, and tested them for significance. We also com-
puted the number of genes annotated with these functional 
terms (the Count value). By selecting the functional catego-
ries with P-value <0.001 and Count >300, we identified 32 
cancer-associated functional terms (Table S3). We observed 
strong enrichment (P-value<1010) for terms such as se-
quence variant, disease mutation, phosphoprotein and alter-
native splicing, in good agreement with what is known 
about cancer-associated processes. 
2.2  Computation of F-scores for identified features 
We detected a total of 55 features that showed significant 
differences between cancer genes and non-cancer genes, 
implying their association with cancer. These features in-
clude four PPI network properties, 19 sequence features and 
32 functional annotation features. The F-scores for all the 
features were computed to measure their ability to discrim-
inate between the cancer genes and the control genes (see 
Materials and methods). The 20 features with the highest 
F-scores are listed in Table 3. The 2N index and ‘disease 
mutation’ were the most discriminative features. The cutoff 
of F-score can be determined according to actual require-
ment, in order to select the subset of features as the input to 
build the classifier of cancer genes and non-cancer genes. 
2.3  Model establishment and evaluation 
Classifiers based on the four methods (logistic regression 
and support vector machines (SVM), BaysNet and decision 
tree) were trained with the positive dataset (cancer genes) 
and the negative dataset (control genes). The PPI network 
features, sequence properties and functional features were 
ranked according their F-scores, and a subset of features 
was selected by setting a cutoff value for the F-scores. The 
selected features were used as input to the classifiers to dis-
tinguish between the cancer and non-cancer genes in the test 
datasets. 
Based on 5-fold cross-validation, we evaluated the per-
formance of the four machine learning classifiers. The AUC 
for the results of the cross-validation are shown in Figure 2. 
Not surprisingly, the models with all features as input did 
not produce the best performances. This might be because 
of the presence of noisy features that make fitting the hy-
perplane more complex. Simpler models were obtained by 
choosing a more relevant subset of features as input and this, 
in turn, produced a better performance from all four classi-
fiers. Specifically, using an F-score cutoff of 0.03, 14 fea-
tures were selected to train the classifiers (see the top 14 
features in Table 3), including three network properties, two 
sequence features and nine functional features. The AUC 
results of the cross-validation of the logistic regression, 
SVM, Baysnet and J48 tree models were 0.834, 0.740, 
0.800 and 0.782, respectively. 
The performance of the classifier based on the logistic 
regression model with a combination of the PPI network, 
sequence, and functional properties was compared with its 
performance with each of the property types separately. In 
all cases, the F-score cutoff was 0.03. The ROCs that we 
obtained using this model with different input are shown in 
Figure 3. The corresponding AUC results of the cross-  
validations for this classifier with all features, and PPI net-
work, sequence and functional features separately were 
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Table 3  The top 20 features with the highest F-scores 
Feature type Feature name F-score 
Network 2N index 0.196 
Function Disease mutation 0.170 
Function Sequence variant 0.059 
Network Connectivity 0.045 
Sequence Molecular weight 0.043 
Sequence Residues 0.043 
Network 1N index 0.036 
Function ATP-binding 0.034 
Function GO 0005524: ATP binding 0.032 
Function GO 0032559: adenyl ribonucleotide binding 0.032 
Function GO 0001882: nucleoside binding 0.032 
Function GO 0001883: purine nucleoside binding 0.032 
Function GO 0030554: adenyl nucleotide binding 0.032 
Function Phosphoprotein 0.031 
Sequence A280 molar extinction coefficient 0.028 
Function Polymorphism 0.027 
Function GO 0032555: purine ribonucleotide binding 0.025 
Function GO 0032553: ribonucleotide binding 0.025 
Function Nucleotide-binding 0.025 
Function GO 0017076: purine nucleotide binding 0.025 
 
 
Figure 2  AUC results of the cross-validations for the four classifiers 
using different F-score cutoffs. 
0.834, 0.768, 0.653 and 0.747, respectively. The results 
show that the logistic regression model with the combina-
tion of features performed better than of the model with the 
individual feature type. Further, the three feature types dif-
fered in their ability to distinguish between the cancer genes 
and the controls. The sequence features were less sensitive 
than the network and functional features for the identifica-
tion of cancer genes. 
2.4  Application of the classifier to identify novel cancer 
genes 
We chose the classifier based on the logistic regression 
 
Figure 3  ROCs of the classifier based on logistic regression using multi-
ple biological evidence and individual evidence as inputs. 
method using all the features selected with an F-score cutoff 
of 0.03, and applied it to identify potential cancer genes in 
the Entrez database [5]. After removing the cancer and 
non-cancer genes from the gene list, the remaining 6907 
genes were imported into the classifier, which predicted that 
1976 genes were associated with cancer (Table S4). Some 
of the predicted cancer genes, which were selected by fixing 
the following thresholds: (i) cancer linker degree 20; (ii) 
molecular weight >8000; and (iii) found in disease mutation, 
are listed in Table 4. These candidate cancer genes will pro-
vide a reference dataset for the design of new experiments 
to improve the understanding of cancer. Further, some of 
these candidates may be developed into important cancer 
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Table 4  Cancer gene candidates predicted using the classifier based on the logistic regression method 
Gene Entrez ID Degree 1N index 2N index Molecular weight 
VCL 7414 130 0.231 0.271 116722 
NR3C1 2908 99 0.323 0.338 85659 
APP 351 88 0.227 0.310 86943 
STAT1 6772 85 0.435 0.375 87334 
HD 3064 63 0.270 0.305 347858 
ITGB3 3690 54 0.296 0.372 87057 
STAT5B 6777 46 0.413 0.424 89865 
ITGB2 3689 45 0.244 0.350 84781 
PTPRC 5788 44 0.341 0.352 147253 
ACTN2 88 44 0.250 0.271 103853 
CASK 8573 41 0.122 0.220 104479 
JUP 3728 37 0.432 0.354 81744 
ITGB4 3691 36 0.417 0.353 202166 
VCP 7415 33 0.212 0.265 89321 
DNM2 1785 32 0.375 0.331 98064 
HSPG2 3339 30 0.167 0.235 468823 
COL2A1 1280 29 0.207 0.297 141785 
C3 718 28 0.179 0.256 187163 
CFTR 1080 28 0.214 0.272 168141 
DSP 1832 27 0.222 0.264 260118 
IKBKAP 8518 25 0.280 0.311 150253 
PKD1 5310 24 0.458 0.323 462415 
COL4A1 1282 24 0.250 0.302 160610 
PLEC1 5339 23 0.435 0.342 518471 
PARD3 56288 23 0.478 0.325 151422 
DMD 1756 22 0.182 0.278 425581 
RIMS1 22999 20 0.250 0.272 189072 
L1CAM 3897 20 0.150 0.292 140002 
 
biomarkers or drug targets. 
3  Conclusion 
Identification of novel cancer genes is important for under-
standing the disease mechanism and for the development of 
cancer therapeutics. In this paper, we integrated multiple 
types of biological evidence, including sequence properties, 
PPI network features and functional features to establish 
prediction models for the identification of potential cancer 
genes. We confirmed the effectiveness of the prediction 
model using 5-fold cross-validation. The validation results 
showed that the integrated prediction models performed 
much better than the logistic regression model based on the 
individual biological evidence. Finally, the logistic regres-
sion model was applied to the Entrez genes to predict can-
didate cancer genes that could be prioritized for experi-
mental validation. 
Because the genes with known functional annotations are 
the genes that have been most widely investigated, there 
may be bias in the functional evidence that was used in this 
study. Therefore, to help eliminate the bias in the individual 
evidence we integrated three types of biological evidence, 
including PPI network, functional and sequence features, to 
identify the potential cancer genes. The method that we 
proposed here is a powerful tool that can be applied not 
only to discover unknown cancer genes, but also to provide 
a comprehensive understanding of cancer from the aspects 
of sequence, function and PPI networks. In future studies, 
we will consider combing more data sources, such as tran-
scriptome, proteome, and protein structure data, into the 
prediction model to further improve its accuracy and appli-
cation range. 
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